tiprankstipranks
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
PremiumPress ReleasesAmryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
1y ago
Amryt Pharma shareholders approve acquisition by Chiesi Farmaceutici
PremiumThe Fly
Amryt Pharma shareholders approve acquisition by Chiesi Farmaceutici
1y ago
Amryt Pharma publishes scheme circular, announces shareholder meetings
PremiumThe Fly
Amryt Pharma publishes scheme circular, announces shareholder meetings
1y ago
Amryt Pharma downgraded to Hold from Buy at Canaccord
PremiumThe FlyAmryt Pharma downgraded to Hold from Buy at Canaccord
1y ago
Amryt Pharma downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe Fly
Amryt Pharma downgraded to Neutral from Overweight at Cantor Fitzgerald
1y ago
Chiesi Farmaceutici S.p.A. to acquire Amryt Pharma
PremiumThe Fly
Chiesi Farmaceutici S.p.A. to acquire Amryt Pharma
1y ago
COMP Adopts Positive Opinion on Orphan Designation for Mycapssa® for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors
PremiumPress ReleasesCOMP Adopts Positive Opinion on Orphan Designation for Mycapssa® for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors
1y ago
European Commission approves Mycapssa® for the treatment of Acromegaly
PremiumPress Releases
European Commission approves Mycapssa® for the treatment of Acromegaly
1y ago
Amryt Pharma announces EC approves Mycapssa for treatment of acromegaly
PremiumThe Fly
Amryt Pharma announces EC approves Mycapssa for treatment of acromegaly
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100